Form 4 for IDXX Idexx Laboratories
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0001567619-23-003222 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-16 | 2023-02-14 | IDXX | Smith Martin Alexander | EVP | F - Tax | $503.65 | +47 | 180 | +35% | +$23.7K |
| D | 2023-02-16 | 2023-02-14 | IDXX | Smith Martin Alexander | EVP | M - OptEx | $0.00 | +149 | 227 | +191% | $0 |
| D | 2023-02-16 | 2023-02-14 | IDXX | Smith Martin Alexander | EVP | M - OptEx | — | -149 | 1,846 | -7% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | F | A | 47 | $503.65 | 180 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-14 | M | A | 149 | $0.00 | 227 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 149 | — | 1,846 | D | — · — to — | 149 Common Stock | (F2) Not applicable. (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |